Matthias Willmann

2.6k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Matthias Willmann is a scholar working on Molecular Medicine, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Matthias Willmann has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 18 papers in Molecular Biology and 11 papers in Clinical Biochemistry. Recurrent topics in Matthias Willmann's work include Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Gut microbiota and health (7 papers). Matthias Willmann is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Gut microbiota and health (7 papers). Matthias Willmann collaborates with scholars based in Germany, Spain and United Kingdom. Matthias Willmann's co-authors include Silke Peter, Matthias Marschal, Ingo B. Autenrieth, Christopher Weidenmaier, Heike Brötz‐Oesterhelt, Bernhard Krismer, Marc Burian, Christoph Slavetinsky, Martin C. Konnerth and Anne Berscheid and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Matthias Willmann

40 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human commensals producing a novel antibiotic impair pathogen colonization

2016 653 citations Christopher Weidenmaier, Matthias Marschal et al. profile →

Peers

Countries citing papers authored by Matthias Willmann

Since Specialization

Citations

This map shows the geographic impact of Matthias Willmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Willmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Willmann more than expected).

Fields of papers citing papers by Matthias Willmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Willmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Willmann. The network helps show where Matthias Willmann may publish in the future.

Co-authorship network of co-authors of Matthias Willmann

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Willmann. A scholar is included among the top collaborators of Matthias Willmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Willmann. Matthias Willmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Signature of Alzheimer’s Disease in Intestinal Microbiome: Results From the AlzBiom Study 2022 ·Frontiers in Neuroscience ·Christoph Laske, Stephan A. Müller, Oliver Preische, (unknown), Matthias H. Munk, (unknown), Silke Peter, (unknown), Matthias Willmann	21
2	Transcriptomic Basis of Serum Resistance and Virulence Related Traits in XDR P. aeruginosa Evolved Under Antibiotic Pressure in a Morbidostat Device 2021 ·Frontiers in Microbiology ·(unknown), (unknown), (unknown), (unknown), Silke Peter, (unknown), Angel Angelov, Sandra Schwarz, Matthias Willmann	10
3	Tracking of Antibiotic Resistance Transfer and Rapid Plasmid Evolution in a Hospital Setting by Nanopore Sequencing 2020 ·mSphere ·Silke Peter, Mattia Bosio, (unknown), Daniela Bezdan, Javier Cuesta, Philipp Oberhettinger, Jan Liese, Wichard Vogel, Daniela Dörfel, (unknown), Matthias Marschal, Matthias Willmann, Marta Gut, Ingo B. Autenrieth, Stephan Ossowski	62
4	Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study 2019 ·BMC Biology ·Matthias Willmann, Maria J. G. T. Vehreschild, Lena M. Biehl, Wichard Vogel, Daniela Dörfel, Axel Hamprecht, Harald Seifert, Ingo B. Autenrieth, Silke Peter	104
5	Dynamics of the human gut phageome during antibiotic treatment 2018 ·Computational Biology and Chemistry ·Anna Górska, Silke Peter, Matthias Willmann, Ingo B. Autenrieth, Robert Schlaberg, Daniel H. Huson	10
6	Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture 2017 ·Antimicrobial Agents and Chemotherapy ·(unknown), Matthias Willmann, Matthias Steglich, Boyke Bunk, Ulrich Nübel, Silke Peter, Richard A. Neher	61
7	In vitrosusceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission 2017 ·Journal of Antimicrobial Chemotherapy ·Alexander Mischnik, (unknown), Axel Hamprecht, Anna M. Rohde, Silke Peter, Susanne Feihl, Johannes K.‐M. Knobloch, (unknown), Axel Kola, (unknown), Christiane Querbach, Matthias Willmann, Friedemann Gebhardt, Evelina Tacconelli, Petra Gastmeier, Harald Seifert, Winfried V. Kern	4
8	Genomic characterisation of clinical and environmental Pseudomonas putida group strains and determination of their role in the transfer of antimicrobial resistance genes to Pseudomonas aeruginosa 2017 ·BMC Genomics ·Silke Peter, Philipp Oberhettinger, Leonard Schuele, Ariane Dinkelacker, Wichard Vogel, Daniela Dörfel, Daniela Bezdan, Stephan Ossowski, Matthias Marschal, Jan Liese, Matthias Willmann	48
9	A simple statistical test of taxonomic or functional homogeneity using replicated microbiome sequencing samples 2016 ·Journal of Biotechnology ·Daniel H. Huson, Mike Steel, Mohamed El-Hadidi, Suparna Mitra, Silke Peter, Matthias Willmann	3
10	Translational metagenomics and the human resistome: confronting the menace of the new millennium 2016 ·Journal of Molecular Medicine ·Matthias Willmann, Silke Peter	18
11	Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission 2016 ·International Journal of Antimicrobial Agents ·Alexander Mischnik, (unknown), Axel Hamprecht, Anna M. Rohde, Silke Peter, Susanne Feihl, Johannes K.‐M. Knobloch, (unknown), Axel Kola, (unknown), Christiane Querbach, Matthias Willmann, Friedemann Gebhardt, Evelina Tacconelli, Petra Gastmeier, Harald Seifert, Winfried V. Kern	13
12	Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics 2015 ·Antimicrobial Agents and Chemotherapy ·Matthias Willmann, Mohamed El-Hadidi, Daniel H. Huson, Monika Schütz, Christopher Weidenmaier, Ingo B. Autenrieth, Silke Peter	49
13	Prevalence and risk factors associated with colonization and infection of extensively drug-resistantPseudomonas aeruginosa: a systematic review 2015 ·Expert Review of Anti-infective Therapy ·Michael Buhl, Silke Peter, Matthias Willmann	72
14	Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study 2014 ·BMC Infectious Diseases ·Matthias Willmann, (unknown), Wichard Vogel, Jan Liese, Matthias Marschal, Ingo B. Autenrieth, Silke Peter, Michael Buhl	19
15	Disease Progression in Plasmodium knowlesi Malaria Is Linked to Variation in Invasion Gene Family Members 2014 ·PLoS neglected tropical diseases ·Md Atique Ahmed, Miguel Pinheiro, Paul C. S. Divis, (unknown), (unknown), (unknown), Chan Lu, (unknown), (unknown), Sean Lynch, Matthias Willmann, Balbir Singh, Sanjeev Krishna, Janet Cox‐Singh	41
16	Emergence of Citrobacter freundii carrying IMP-8 metallo-β-lactamase in Germany 2014 ·New Microbes and New Infections ·Silke Peter, Christiane Wolz, Martin Kaase, Matthias Marschal, Berit Schulte, Wichard Vogel, Ingo B. Autenrieth, Matthias Willmann	9
17	Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosabloodstream infection: a retrospective cohort study 2013 ·BMC Infectious Diseases ·Matthias Willmann, (unknown), Matthias Marschal, Klaus Schröppel, Wichard Vogel, Ingo Flesch, (unknown), Ingo B. Autenrieth, (unknown), Silke Peter	18
18	Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study 2012 ·Malaria Journal ·Matthias Willmann, Md Atique Ahmed, (unknown), (unknown), (unknown), Balbir Singh, Sanjeev Krishna, Janet Cox‐Singh	50
19	Members of a mammalian SNARE complex interact in the endoplasmic reticulum in vivo and are found in COPI vesicles 2008 ·European Journal of Cell Biology ·(unknown), Matthias Willmann, Dirk Wenzel, Ulrike Winter, Gabriele Fischer von Mollard, Hans‐Dieter Söling	13
20	Durch Ehrlichia canis verursachte Nierenamyloidose 2003 ·Schweizer Archiv für Tierheilkunde ·Nicole Luckschander, Miriam Kleiter, Matthias Willmann	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact